Iterum Therapeutics PLC (ITRM) — Net Asset Momentum

Latest YoY growth as of December 2024: +36.3%

Iterum Therapeutics PLC (ITRM) recorded a net asset momentum of 36.3% as of December 2024, with net assets of $-4.08 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Iterum Therapeutics PLC net assets for net asset value and shareholders' equity analysis.

YoY Momentum

+36.3%
Year-over-year

Current Net Assets

$-4.08 Million
USD · December 2024

Years of Data

9
2016 – 2024

Country

USA
NASDAQ

Iterum Therapeutics PLC Net Asset Momentum (2016–2024)

This chart tracks Iterum Therapeutics PLC's year-over-year net asset growth across 9 annual reporting periods from 2016 to 2024. The most recent momentum reading is +36.3%, with net assets of $-4.08 Million USD as of December 2024. For live market cap and overall valuation, see market value of Iterum Therapeutics PLC.

Annual Net Asset History for Iterum Therapeutics PLC (2016–2024)

The table below shows the complete annual net asset history for Iterum Therapeutics PLC from 2016 to 2024, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check ITRM tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Year Net Assets (USD) Total Assets Total Liabilities YoY Momentum
2024 $-4.08 Million $44.59 Million $48.68 Million ▲ +36.3%
2023 $-6.40 Million $26.26 Million $32.66 Million ▼ -122.9%
2022 $28.00 Million $66.83 Million $38.83 Million ▼ -44.3%
2021 $50.23 Million $91.51 Million $41.27 Million ▲ +199.4%
2020 $-50.56 Million $32.79 Million $83.35 Million ▼ -92.7%
2019 $-26.24 Million $25.75 Million $51.99 Million ▼ -136.6%
2018 $71.62 Million $97.87 Million $26.25 Million ▲ +81.3%
2017 $39.49 Million $46.76 Million $7.26 Million ▲ +74.2%
2016 $22.67 Million $26.92 Million $4.25 Million